IRS1 and psoriasis: The chronic inflammation inherent in psoriasis leads to the activation of immune cells and the release of cytokines that disrupt insulin signaling pathways, mainly through the serine phosphorylation of insulin receptor substrate-1 (IRS-1), thereby promoting insulin resistance [132].